Los Angeles Capital Management
BHVN icon

Los Angeles Capital Management’s Biohaven BHVN Stock Holding History

Los Angeles Capital Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.21K Hold
379
– – ﹤0.01% 2226
2025
Q4 		$6.59K Buy
+379
New +$4.7K ﹤0.01% 2219

Other funds holding BHVN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $173M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Los Angeles Capital Management's BHVN Position: Q1 2026 in Review

Los Angeles Capital Management held its Biohaven (BHVN) position steady in Q1 2026 at 379 shares worth $3.21K. The position accounts for ﹤0.01% of the portfolio, ranked #2226.

Los Angeles Capital Management first reported a position in BHVN in Q4 2025 and has held it in 2 quarters since. The position peaked at $6.59K in Q4 2025. 275 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

  • Los Angeles Capital Management held 379 shares of Biohaven worth $3.21K as of Q1 2026.
  • Los Angeles Capital Management left its Biohaven share count unchanged in Q1 2026.
  • Biohaven made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #2226 holding.
  • Los Angeles Capital Management first reported a position in Biohaven in Q4 2025 and has held it in 2 quarters since.
  • Los Angeles Capital Management's Biohaven position peaked at $6.59K in Q4 2025.
  • 275 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.